IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — MGNX

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.110.070.080.130.150.180.080.080.090.110.220.080.020.050.190.190.22
Accounts Receivable0.020.010.070.010.010.010.010.010.030.010.040.010.020.010.010.050.01
Inventory--0.010.010.010.010.000.000.000.000.000.000.000.000.000.000.010.01
Total Current Assets0.320.180.230.200.180.220.160.200.290.250.290.150.170.220.330.370.37
Property, Plant & Equipment0.000.010.010.020.020.020.020.020.020.020.030.030.030.040.040.040.04
Total Non-current Assets*0.020.040.040.040.040.040.040.050.050.050.050.050.050.050.060.060.06
Total Assets0.350.220.270.250.220.260.200.250.340.310.340.200.220.270.390.430.44
Accounts Payable0.000.000.010.000.010.010.010.010.000.000.000.000.000.000.010.010.01
Total Current Liabilities0.110.100.040.040.060.060.060.060.050.050.050.050.050.070.070.070.05
Total Non-current Liabilities*0.190.100.160.160.090.090.090.090.090.090.190.020.020.030.030.040.03
Total Liabilities0.300.200.200.200.150.140.140.140.150.130.230.070.080.090.100.110.08
Retained Earnings(1.26)(1.28)(1.23)(1.25)(1.21)(1.15)(1.21)(1.15)(1.06)(1.07)(1.13)(1.11)(1.08)(1.04)(0.92)(0.86)(0.82)
Total Stockholder Equity0.040.020.070.050.080.120.060.110.190.170.110.120.140.180.290.320.35

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue32.8320.7841.2372.8422.2413.1919.35110.7110.809.1010.7210.4013.1424.5073.1041.7326.0111.1014.1515.66
Cost of Revenue----0.000.000.000.000.230.170.180.270.160.090.260.110.123.010.180.050.951.67
Gross Profit----41.2372.8422.2413.1919.12110.5410.628.8310.5610.3112.8824.3872.9838.7325.8311.0513.2014.00
Research & Development38.7834.9733.9732.7140.7939.7038.8940.5451.7346.0347.3530.1343.2345.8745.6548.1951.7461.4455.8549.82
Selling, General & Admin7.909.719.249.909.3010.7227.8114.1014.4214.7112.5612.4113.6913.5313.6715.3613.6716.2515.5817.16
Total Operating Expenses----53.3254.2059.0055.8271.9656.3568.8062.5859.9145.8157.8462.8161.0063.6867.6477.6971.4466.98
Operating Income(13.85)(33.44)(12.09)18.64(36.76)(42.62)(52.84)54.19(58.18)(53.75)(49.35)(35.50)(44.96)(38.43)11.98(24.95)(41.81)(66.64)(58.24)(52.99)
Interest Expense4.404.89--3.340.800.09(0.02)0.000.011.130.000.000.77--------------
Pretax Income(69.64)--(14.93)16.82(36.15)------------------------------
Tax Provision0.00--(0.78)0.000.11------------------------------
Net Income19.52(36.77)(14.15)16.82(36.25)(41.04)(15.42)56.31(55.66)(52.19)(46.07)17.5557.47(38.01)12.80(24.81)(41.30)(66.44)(58.02)(52.89)
Basic EPS0.31(0.58)(0.23)0.27(0.57)(0.65)(0.24)0.90(0.89)(0.84)(0.75)0.280.93(0.61)0.20(0.40)(0.67)(1.08)--(0.86)
Diluted EPS0.31(0.58)(0.23)0.27(0.57)(0.65)(0.24)0.90(0.89)(0.84)(0.74)0.280.92(0.61)0.20(0.40)(0.67)(1.08)--(0.86)

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(40.75)(35.81)43.02(30.19)(46.98)(46.89)(38.41)60.16(44.48)(45.64)(28.04)(35.25)(2.09)(12.83)29.32(9.42)(49.16)(57.70)(54.31)(14.79)
Capital Expenditures0.810.340.240.430.720.530.620.591.031.460.620.500.290.360.390.801.011.421.382.13
Free Cash Flow*(41.55)(36.15)42.78(30.61)(47.70)(47.42)(39.03)59.57(45.52)(47.10)(28.66)(35.74)(2.37)(13.19)28.93(10.23)(50.17)(59.11)(55.68)(16.93)
Investing Cash Flow27.9745.32(65.99)(20.37)(37.64)9.9041.4735.6047.4424.7938.82(33.52)(113.48)28.10(5.79)71.9523.04(18.48)(13.55)(2.62)
Financing Cash Flow60.17(0.21)0.060.0069.74(0.28)0.16(0.07)0.630.250.2749.910.06100.121.360.000.260.040.8018.97

* Derived from reported values